Emily's Entourage

Emily’s Entourage is an innovative 501(c)3 foundation that accelerates research and drug development for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations. By providing critical leadership and coordination, Emily’s Entourage drives high-impact research, cultivates multi-stakeholder collaboration, and facilitates information exchange to speed breakthroughs. Since 2011, Emily's Entourage has awarded millions of dollars in research grants, launched a CF gene therapy company recently acquired by a large pharmaceutical company, and led worldwide efforts to drive high-impact research and drug development. The organization has been featured in national media, including the New York Times, STAT, CNN, People, and more.